Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

Hematopoietic stem cell transplantation (HSCT) is a lifesaving expensive medical procedure. Hence, more transplants are performed in more affluent countries. The impact of economic factors on patient outcome is less defined. We analyzed retrospectively a defined cohort of 102,549 patients treated wi...

Full description

Bibliographic Details
Main Authors: Alois Gratwohl, Anna Sureda, Helen Baldomero, Michael Gratwohl, Peter Dreger, Nicolaus Kröger, Per Ljungman, Eoin McGrath, Mohamad Mohty, Arnon Nagler, Alessandro Rambaldi, Carmen Ruiz de Elvira, John A. Snowden, Jakob Passweg, Jane Apperley, Dietger Niederwieser, Theo Stijnen, Ronald Brand
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:EBioMedicine
Subjects:
Hematopoietic stem cell transplantation
Macroeconomics
Microeconomics
Center effect
Patient volume
Program duration
Outcome
Survival
GNI/cap
HCE/cap
HDI
Risk assessment
Online Access:http://www.sciencedirect.com/science/article/pii/S235239641530205X

Internet

http://www.sciencedirect.com/science/article/pii/S235239641530205X

Similar Items